Uptake of new treatment strategies for deep vein thrombosis: an international audit.

Details

Ressource 1Download: serval:BIB_05930D25F075.P001 (114.68 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_05930D25F075
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Uptake of new treatment strategies for deep vein thrombosis: an international audit.
Journal
International Journal for Quality in Health Care
Author(s)
Aujesky D.A., Cornuz J., Bosson J.L., Bounameaux H., Emmerich J., Hull R.D., Mackay E., Perrier A., Quan H., Tsuyuki R.T., Ghali W.A.
ISSN
1353-4505
Publication state
Published
Issued date
2004
Peer-reviewed
Oui
Volume
16
Number
3
Pages
193-200
Language
english
Abstract
OBJECTIVE: Study of the uptake of new medical technologies provides useful information on the transfer of published evidence into usual practice. We conducted an audit of selected hospitals in three countries (Canada, France, and Switzerland) to identify clinical predictors of low-molecular-weight (LMW) heparin use and outpatient treatment, and to compare the pace of uptake of these new therapeutic approaches across hospitals. DESIGN: Historical review of medical records. SETTING AND PARTICIPANTS: We reviewed the medical records of 3043 patients diagnosed with deep vein thrombosis (DVT) in five Canadian, two French, and two Swiss teaching hospitals from 1994 to 1998. Measures. We explored independent clinical variables associated with LMW heparin use and outpatient treatment, and determined crude and adjusted rates of LMW heparin use and outpatient treatment across hospitals. RESULTS: For the years studied, the overall rates of LMW heparin use and outpatient treatment in the study sample were 34.1 and 15.8%, respectively, with higher rates of use in later years. Many comorbidities were negatively associated with outpatient treatment, and risk-adjusted rates of use of these new approaches varied significantly across hospitals. CONCLUSION: There has been a relatively rapid uptake of LMW heparins and outpatient treatment for DVT in their early years of availability, but the pace of uptake has varied considerably across hospitals and countries.
Keywords
Aged, Ambulatory Care, Anticoagulants/therapeutic use, Canada, Female, France, Health Services Research, Heparin, Low-Molecular-Weight/therapeutic use, Humans, Male, Medical Audit, Middle Aged, Patient Care, Switzerland, Venous Thrombosis/drug therapy
Pubmed
Web of science
Open Access
Yes
Create date
05/03/2008 15:56
Last modification date
25/09/2019 6:08
Usage data